Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 N State St
# Ummc
Jackson, MS 39216Phone+1 601-984-5517Fax+1 601-984-5503
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2011 - 2013
Vanderbilt University Medical CenterResidency, Neurology, 2008 - 2011- Vanderbilt University Medical CenterInternship, Internal Medicine, 2007 - 2008
University of Alabama School of MedicineClass of 2007
Certifications & Licensure
MS State Medical License 2013 - 2025
TX State Medical License 2011 - 2014- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). Start of enrollment: 2016 Jul 01
- Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma Start of enrollment: 2018 May 20
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Start of enrollment: 2019 Jul 30
Publications & Presentations
PubMed
- Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation.Wesley Wang, Zeynep Temerit Kumm, Cindy Ho, Ideli Zanesco-Fontes, Gustavo Texiera
Neuro-Oncology Advances. 2023-11-11 - 1 citationsClinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary
British Journal of Neurosurgery. 2023-06-07 - 20 citationsCancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu
Cell Reports. Medicine. 2023-05-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
